ClinicalTrials.gg
Not yet recruitingNCT07939243Updated Nov 16, 2026

Effect of Fibular Head Manipulation on Improving Knee Joint Pain and Range of Motion in Patients With Knee Osteoarthritis

An interventional study of One-shot manipulation of the head of the fibula (Fibular head mobilization/manipulation) in Knee Osteoarthritis and Knee Joint Osteoarthritis, sponsored by Kafrelsheikh University. Not yet recruiting. Open to participants aged 25 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Kafrelsheikh University · Not applicable, Interventional, and Treatment

Updated Nov 16, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
25 Years to 65 Years
Sex
All
01

Study summary

The goal of this pre-post randomized controlled experimental trial is to examine the effect of fibular head mobilization and manipulation on knee pain, stiffness, and range of motion (ROM) in patients with knee osteoarthritis. The study focuses on 40 participants of both genders, ranging in age from 25 to 65 years.

Main Questions

  • Does fibular head mobilization improve knee pain and range of motion in patients with knee osteoarthritis?
  • What is the impact of fibular head mobilization on knee stiffness and joint function?

Study Design and Comparison

Researchers will compare a treatment group receiving a one-shot manipulation of the head of fibula against a comparison/control group (with study procedures also noting randomized allocation approaches).

Participant Tasks and Evaluation

Participants will:

  • Be randomly assigned into two equal groups of 20 patients each.
  • Have their knee range of motion measured using an electronic goniometer.
  • Have their knee pain measured using a numeric scale.
  • Have their knee function assessed using a knee joint functional index.
02

Conditions studied

  • Knee Osteoarthritis
  • Knee Joint Osteoarthritis

Keywords

  • Fibular head manipulation
  • Fibular head mobilization
  • Knee osteoarthritis (OA)
  • Knee joint pain
  • Range of motion (ROM)
  • Physical therapy
  • Proximal tibiofibular joint
03

In context

Osteoarthritis, Knee

3,295 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

This study's planned enrollment of 40 is below the median of 68 across 2,716 interventional studies indexed under Osteoarthritis, Knee.

Browse Osteoarthritis, Knee studies →

Lead sponsor

Kafrelsheikh University is the lead sponsor of 300 studies on the registry; 119 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants must have knee joint osteoarthritis (OA).
  • Participants must be between 25 and 65 years of age.
  • Both genders are eligible to participate.
  • Participants must sign a consent form according to the Helsinki Protocol.

Exclusion criteria

Exclusion Criteria:

  • A history of recent lower extremity surgery (such as knee replacement, arthroscopy, or ligament reconstruction) in the affected leg.
  • Acute knee trauma, bone fracture, or severe ligamentous instability (such as acute ACL or collateral ligament tears).
  • Inflammatory or systemic arthritic conditions other than osteoarthritis (such as rheumatoid arthritis, gout, or ankylosing spondylitis).
  • Known local to manual therapy or manipulation around the proximal fibula (such as local skin infection, active tumor, or severe osteoporosis).
  • History of proximal fibular fracture or existing peroneal nerve palsy/injury.
  • Neurological conditions affecting lower limb sensation or motor function (such as stroke, peripheral neuropathy, or radiculopathy).
  • Received physical therapy, intra-articular injections (such as or hyaluronic acid), or other targeted treatments for knee pain within the past 4 to 6 weeks.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Fibular Head Manipulation Group

    Participants in this group will receive a one-shot manipulation of the head of the fibula

    Procedure: One-shot manipulation of the head of the fibula (Fibular head mobilization/manipulation)

  • No intervention
    Control Group

    control group will not receive any treatment

Interventions

  • ProcedureOne-shot manipulation of the head of the fibula (Fibular head mobilization/manipulation)

    Participants receive a single session (one-shot) of fibular head manipulation to examine its effects on knee pain, range of motion, and stiffness

06

What researchers measure

Primary outcomes

  1. Knee range of motion will be measured by electronic goniometer

    Time frame: Pre-intervention and post-intervention (measured at baseline and immediately following the one-shot treatment session)

Secondary outcomes

  1. Knee pain will be measured by numeric anlage scale

    Time frame: Pre-intervention and post-intervention (measured at baseline and immediately following the one-shot treatment session)

  2. Knee function will be assessed by knee joint functional index

    Time frame: Pre-intervention and post-intervention (measured at baseline and immediately following the one-shot treatment session)

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Nichols JA, Baratta C, Reb CW. Biomechanical Sequelae of Syndesmosis Injury and Repair. Foot Ankle Clin. 2023 Mar;28(1):77-98. doi: 10.1016/j.fcl.2022.10.004. Epub 2023 Jan 2. PubMed 36822690 ↗
  • Poage C, Roth C, Scott B. Peroneal Nerve Palsy: Evaluation and Management. J Am Acad Orthop Surg. 2016 Jan;24(1):1-10. doi: 10.5435/JAAOS-D-14-00420. PubMed 26700629 ↗
  • Ogden JA. The anatomy and function of the proximal tibiofibular joint. Clin Orthop Relat Res. 1974 Jun;(101):186-91. No abstract available. PubMed 4837930 ↗
  • Scott J, Lee H, Barsoum W, van den Bogert AJ. The effect of tibiofemoral loading on proximal tibiofibular joint motion. J Anat. 2007 Nov;211(5):647-53. doi: 10.1111/j.1469-7580.2007.00803.x. Epub 2007 Aug 31. PubMed 17764523 ↗
  • Resnick D, Newell JD, Guerra J Jr, Danzig LA, Niwayama G, Goergen TG. Proximal tibiofibular joint: anatomic-pathologic-radiographic correlation. AJR Am J Roentgenol. 1978 Jul;131(1):133-8. doi: 10.2214/ajr.131.1.133. PubMed 97965 ↗
  • Gupton M, Munjal A, Kang M. Anatomy, Bony Pelvis and Lower Limb: Fibula. 2023 May 23. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK470591/ PubMed 29261984 ↗
  • Waxenbaum JA, Sina RE, Lu M. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Feb 15, 2026. Physiology, Muscle Energy. [PubMed]
  • Goodridge JP. Muscle energy technique: definition, explanation, methods of procedure. J Am Osteopath Assoc. 1981 Dec;81(4):249-54. No abstract available. PubMed 7319853 ↗
  • Ingold CJ, Ratay S. Osteopathic Manipulative Treatment: HVLA Procedure - Inhaled Ribs. 2023 Jul 31. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK562299/ PubMed 32965970 ↗
  • Bodine WA. Osteopathic Manipulative Treatment: A Primary Care Approach. Am Fam Physician. 2019 Feb 15;99(4):214. No abstract available. PubMed 30763051 ↗

Individual participant data

Plan to share: Undecided — Data will be shared upon reasonable request from the principal investigator.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Dec 2026, 1 month later.

Of 1,111 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 1 month is below that.

Counting every sponsor, half of 1,251 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 10, 2026
First posted
Nov 16, 2026
StartEst.
Nov 10, 2026
Primary completionEst.
Dec 10, 2026
CompletionEst.
Dec 11, 2026
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07939243
Responsible party
yasmein mohammed mahmoud (Dr, Kafrelsheikh University) — Principal investigator
First posted
Nov 16, 2026
Start date
Nov 10, 2026 (estimated)
Primary completion
Dec 10, 2026 (estimated)
Completion
Dec 11, 2026 (estimated)
Last update
Nov 16, 2026

Study contacts

Reda Fathi Elbosaty, bachelor student
Contact
redafathi015@gmail.com
+201555401579
Mohammed Abdelaziz Emam, master degree, Ass.lecturer
principal investigator · faculty of physical therapy, kafr elshiekh university
Reda Fathi Elbosaty, master degree, Ass.lecturer
principal investigator · faculty of physical therapy, kafr elshiekh university
Yasmein Mohammed Mahmoud, PhD
principal investigator · faculty of physical therapy, kafr elshiekh university

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion